Kobo Biotech Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 487832,
    "name": "Kobo Biotech",
    "stock_name": "Kobo Biotech",
    "full_name": "Kobo Biotech Ltd",
    "name_url": "stocks-analysis/kobo-biotech",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2.31",
    "chg": -0.1,
    "chgp": "-4.15%",
    "dir": -1,
    "prev_price": "2.41",
    "mcapval": "6.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531541,
    "symbol": "",
    "ind_name": "Commodity Chemicals",
    "ind_code": 11,
    "indexname": "India SENSEX",
    "isin": "INE881A01015",
    "curr_date": "Apr 06",
    "curr_time": "",
    "bse_nse_vol": "1.41 k",
    "exc_status": "Active",
    "traded_date": "Apr 06, 2026",
    "traded_date_str": "2026 04 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kobo-biotech-487832-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Kobo Biotech Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Poor Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kobo-biotech-ltd-downgraded-to-strong-sell-amid-weak-fundamentals-and-poor-financial-trends-3929659",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KoboBiotechLtd_mojoScore_3929659.png",
        "date": "2026-04-02 08:23:57",
        "description": "Kobo Biotech Ltd, a micro-cap player in the commodity chemicals sector, has been downgraded from a Sell to a Strong Sell rating as of 1 April 2026. This decisive change reflects deteriorating fundamentals, poor valuation metrics, a negative financial trend, and weak technical signals, signalling heightened risk for investors amid ongoing operational challenges and market underperformance."
      },
      {
        "title": "Kobo Biotech Ltd Rating Upgraded to Sell Amid Mixed Technical and Fundamental Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kobo-biotech-ltd-rating-upgraded-to-sell-amid-mixed-technical-and-fundamental-signals-3895923",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KoboBiotechLtd_mojoScore_3895923.png",
        "date": "2026-03-17 08:30:54",
        "description": "Kobo Biotech Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 16 March 2026. This change reflects a nuanced shift driven primarily by technical indicators, even as the company’s fundamental and valuation metrics remain under pressure. The upgrade highlights a cautiously optimistic technical outlook amid persistent financial challenges and subdued market performance."
      },
      {
        "title": "Kobo Biotech Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kobo-biotech-ltd-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3845216",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KoboBiotechLtd_mojoScore_3845216.png",
        "date": "2026-02-18 08:20:32",
        "description": "Kobo Biotech Ltd, a player in the commodity chemicals sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 17 Feb 2026. This revision reflects deteriorating technical indicators, weak financial trends, poor valuation metrics, and declining quality scores, signalling heightened risk for investors amid ongoing operational challenges and market underperformance."
      },
      {
        "title": "Kobo Biotech Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kobo-biotech-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-3836743",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KoboBiotechLtd_mojoScore_3836743.png",
        "date": "2026-02-13 08:20:19",
        "description": "Kobo Biotech Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 12 February 2026. This change reflects a nuanced shift primarily driven by technical indicators, even as the company’s fundamental and valuation metrics remain under pressure. Investors should weigh the recent mild bullish technical trends against persistent operational challenges and weak long-term financial performance."
      }
    ],
    "total": 183,
    "sid": "487832",
    "stock_news_url": "https://www.marketsmojo.com/news/kobo-biotech-487832"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "30-Mar-2026",
      "details": "Intimatioin for Closure of Trading Window for Financial Resilt for March 312026",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "11-Feb-2026",
      "details": "Submission of certificate under Reg. 74(5) of SEBI (DP) 30.09.2024",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "11-Feb-2026",
      "details": "Submission of certificate under Reg. 74(5) of SEBI (DP) 30.06.2024",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kobo Biotech Ltd has declared <strong>10%</strong> dividend, ex-date: 21 Sep 12",
          "dt": "2012-09-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kobo Biotech Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Poor Financial Trends

2026-04-02 08:23:57

Kobo Biotech Ltd, a micro-cap player in the commodity chemicals sector, has been downgraded from a Sell to a Strong Sell rating as of 1 April 2026. This decisive change reflects deteriorating fundamentals, poor valuation metrics, a negative financial trend, and weak technical signals, signalling heightened risk for investors amid ongoing operational challenges and market underperformance.

Read full news article

Kobo Biotech Ltd Rating Upgraded to Sell Amid Mixed Technical and Fundamental Signals

2026-03-17 08:30:54

Kobo Biotech Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 16 March 2026. This change reflects a nuanced shift driven primarily by technical indicators, even as the company’s fundamental and valuation metrics remain under pressure. The upgrade highlights a cautiously optimistic technical outlook amid persistent financial challenges and subdued market performance.

Read full news article

Kobo Biotech Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals

2026-02-18 08:20:32

Kobo Biotech Ltd, a player in the commodity chemicals sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 17 Feb 2026. This revision reflects deteriorating technical indicators, weak financial trends, poor valuation metrics, and declining quality scores, signalling heightened risk for investors amid ongoing operational challenges and market underperformance.

Read full news article

Kobo Biotech Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-02-13 08:20:19

Kobo Biotech Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 12 February 2026. This change reflects a nuanced shift primarily driven by technical indicators, even as the company’s fundamental and valuation metrics remain under pressure. Investors should weigh the recent mild bullish technical trends against persistent operational challenges and weak long-term financial performance.

Read full news article

View All News